Browsing Tag
NPM-119 clinical trial
1 post
FDA clears Vivani Medical’s IND for NPM-119 in type 2 diabetes
Vivani Medical, Inc. (Nasdaq: VANI), a pioneer in biopharmaceutical innovations, has reached a pivotal milestone as the U.S.…